opentrade on
↗
event6 outcomes
When will the FDA reclassify BPC-157 to Category 1?
vol cum
$90.2k
vol 24h
$1.3k
outcomes
6
ends
Jan 8, 2027
outcomesclick to inspect →
showing 5 of 6
marketselected outcome
Before 2027
rank #1
United States
30¢
▼ 9.0pp
24h change
vol cum
$16.2k
vol 24h
$1.3k
spread
0.06
ends
Jan 8, 2027
If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Jan 1, 2027, then the market resolves to Yes.
timeline
opened · Mar 24, 2026opencloses · Jan 8, 2027
Before 2027 · prices over time
−24h
now
volume · by outcomehover a column to inspect
no volume history
similar markets
suggested by pdataFDA moves BPC-157 to Category 1 by…?
December 31, 202648¢▼ 2.5ppAugust 31, 20260¢
$0 24h · 2 markets
Will the FDA approve retatrutide?
Before Jan 1, 202710¢▲ 3.0ppBefore Jul 1, 202743¢▼ 3.0ppBefore Jan 1, 202889¢▲ 2.0pp
+2 others
$364 24h · 5 markets
Will AOH1996 be FDA approved before 2040?
yes40¢
M0 24h · 1 market
FDA approves Retatrutide this year?
yes3¢▼ 0.4pp
$0 24h · 1 market
Will the FDA approve VERVE-102?
Before 203587¢· 0.0ppBefore 203481¢· 0.0ppBefore 203276¢· 0.0pp
+3 others
$0 24h · 6 markets
Will marijuana cease to be classified as a Schedule 1 drug under the U.S. Controlled Substances Act by January 1, 2030?
yes91¢
M0 24h · 1 market